Advances in Liver Disease

Advances in Liver Disease is organized by The Ohio University Center For Continuing Medical Education (OSUCCME).

Event Dates: 01/04/2019 - 01/04/2022

Accreditation:
AMA Credit Designation Statement
The Ohio State University Center for Continuing Medical Education (CCME) designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ABIM MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Description:
Today on MedNet21, we're going to discuss Advances in Liver Disease.

This activity will update physicians regarding the current management of hepatitis C and non-alcoholic steatohepatitis. Additionally, the current liver scoring systems will be discussed.

Objective(s):
As a result of this educational activity, webcast participants will be able to:  Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options. You’ll also learn about the following:
• Causes of liver disease in the United States
• Hepatitis C
• The economics of treating hepatitis C
• Transmission of hepatitis C

Additional details will be posted as soon as information is available.